Philip Morris International (PMI) can thank the emerging market of heat-not-burn for not only meeting but beating recent revenue estimates.
Earlier this year, the U.S. Food and Drug Administration (FDA) gave Altria approval to sell IQOS in the U.S. [read more here]. There are plans for IQOS to be released in Atlanta sometime this summer. PMI has been working with Altria to share how it introduced IQOS so the European market in hopes of making the rollout in the U.S. just as successful.
It was announced that PMI beat its second-quarter earnings and revenue estimates as IQOS, its heat-not-burn device, gained momentum. IQOS’ growth led to shares of the company being up nearly 10 percent.
Continue Reading On: Tobacco Business Magazine